Buy Novocure Stock | NVCR Stock Price & Latest News | Public
NVCR

Novocure

$0.00 (0.00%)Today

    About NVCR

    NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.09
    0.06
    0.03
    0
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    $0.08

    Actual EPS
    Q4 2020

    Stats

    Market Cap$11,87B
    Volume26,88k
    Price-to-Earnings Ratio659.58
    Dividend Rate
    Dividend Yield
    1 Year High$140.89
    1 Year Low$53.40
    Open$119.05
    High$127.55
    Low$119.05

    Buy any stock with any amount of money.

    Download the App
    Download the app